Evidence map›Paper›PMID 31631402›Full record

ArticleMagnetic resonance in medicine2020

Cell penetrating peptide functionalized perfluorocarbon nanoemulsions for targeted cell labeling and enhanced fluorine-19 MRI detection.

Dina V Hingorani, Fanny Chapelin, Emma Stares, Stephen R Adams, Hideho Okada, Eric T Ahrens

Abstract read
In one paragraph

Article in Magnetic resonance in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Single-Residue Substitution of Opicalcin1 Enhances Cellular Uptake but Reduces CaChembiochem : a European journal of chemical biology · 2026
    Article
  2. Review
  3. Article
  4. Receptor-Mediated SPION Labeling of CD4Nanomaterials (Basel, Switzerland) · 2025
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Feasibility and optimization ofPhysics in medicine and biology · 2024
    Article
  10. Article
  11. A primer onFrontiers in medicine · 2023
    Review
  12. Review
  13. Article
  14. Review
  15. MRI techniques for immunotherapy monitoring.Journal for immunotherapy of cancer · 2022
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dina V HingoraniDepartment of Radiology, University of California San Diego, California.
Fanny ChapelinDepartment of Bioengineering, University of California San Diego, California.
Emma StaresDepartment of Radiology, University of California San Diego, California.
Stephen R AdamsDepartment of Pharmacology, University of California San Diego, California.
Hideho OkadaDepartment of Neurological Surgery, University of California San Francisco, California.
Eric T AhrensDepartment of Radiology, University of California San Diego, California.ORCID 0000-0001-6131-9304

Funding

CLINICAL TRANSLATION OF 19F MRI TO VISUALIZE CANCER IMMUNOTHERAPEUTIC CELLSR01CA134633 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AHRENS, ERIC T., COHEN, EZRA · 2009 to 2021
$4.4M
Compositions and methods for enhanced fluorine-19 magnetic resonance imaging cell trackingR01EB024015 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AHRENS, ERIC T. · 2017 to 2020
$2.3M
Intracellular oxygen sensing using 19F MRIR01EB017271 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AHRENS, ERIC T. · 2013 to 2016
$1.3M
19F MRI PROBES AND AUTOIMMUNE DISEASER01EB003453 · NIBIB · CARNEGIE-MELLON UNIVERSITY · PI AHRENS, ERIC T. · 2005 to 2008
$1.1M
Novel adoptive transfer therapy for glioma using CAR-transduced Type17 T-cellsR21NS083171 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI OKADA, HIDEHO · 2014 to 2015
$791k
NCI NIH HHS R01 CA134633NIBIB NIH HHS R01 EB003453NIBIB NIH HHS R01 EB017271NIBIB NIH HHS R01 EB024015NINDS NIH HHS R21 NS083171
6 · The paper itself

Abstract

purposeA bottleneck in developing cell therapies for cancer is assaying cell biodistribution, persistence, and survival in vivo. Ex vivo cell labeling using perfluorocarbon (PFC) nanoemulsions, paired with

methodsWe performed ex vivo labeling of primary human chimeric antigen receptor (CAR) T cells with nanoemulsion. Intracellular labeling was validated using electron microscopy and confocal imaging. To detect signal enhancement in vivo, labeled CAR T cells were intra-tumorally injected into mice bearing flank glioma tumors.

resultsBy incorporating TAT into the nanoemulsion, a labeling efficiency of ~10

conclusionThe peptide-PFC nanoemulsion synthesis scheme presented can significantly enhance cell labeling and imaging sensitivity and is generalizable for other targeted imaging probes.

Indexed as

Fluorine-19 Magnetic Resonance ImagingAnimalsBrain NeoplasmsCell Line, TumorCell-Penetrating PeptidesCell TrackingEmulsionsFemaleFluorocarbonsGlioblastomaGliomaHumansJurkat CellsMiceMice, Inbred NODMice, SCIDCell-Penetrating PeptidesEmulsionsFluorocarbonsReceptors, Chimeric Antigentat Gene Products, Human Immunodeficiency Viruscell-penetrating peptidecell therapyfluorine-19 MRIimmunotherapyin vivo cytometryperfluorocarbon

Identifiers

PMID31631402
PMCPMC6879799

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.